REG - J.P. Morgan Sec PLC - Stabilisation Notice

Goldman SachsAnnouncement

02/04/2025 11:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250402:nRSB3400Da&default-theme=true

RNS Number : 3400D  J.P. Morgan Securities PLC.  02 April 2025

2(nd) April 2025

Not for distribution, directly or indirectly, in or into the United States or
any jurisdiction in which such distribution would be unlawful.

Advanz Pharma issuing under Cidron Aida Finco S.à r.l.

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 1st April 2025,
J.P. Morgan Securities PLC, (contact: Natalie Netter Day 0207 134 2468) hereby
gives notice that no stabilisation (within the meaning of Article 3.2(d) of
the Market Abuse Regulation (EU/596/2014) or the rules of the Financial
Conduct Authority) was undertaken by the Stabilisation Manager(s) named below
in relation to the offer of the following securities.

 Issuer:                    Advanz Pharma issuing under Cidron Aida Finco S.à r.l..
 Guarantor (if any):        N/A
 Aggregate nominal amount:  EUR 615mm

GBP 250mm
 Description:               EUR 6.5-Non-Call-2.5-year Senior Secured Notes

                            GBP 6.5-Non-Call-2.5-year Senior Secured Notes

                            Listing: The international Stock Exchange
 Stabilisation Manager(s):  J.P. Morgan Securities PLC (Stabilisation coordinator)

                            Goldman Sachs (Stabilisation manager)

                            Barclays (Stabilisation manager)

                            Intesa (Stabilisation manager)

                            Jeffries (Stabilisation manager)

                            Morgan stanley (Stabilisation manager)

                            RBC (Stabilisation manager)
 Offer price:               100.000% for both

 

This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or
dispose of any securities of the Issuer in any jurisdiction

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  STAEAPLAESXSEEA